荃信生物-B11月18日耗资约99.94万港元回购4.88万股
Qyuns TherapeuticsQyuns Therapeutics(HK:02509) Zhi Tong Cai Jing·2025-11-18 12:40

Core Viewpoint - The company, 荃信生物-B (02509), announced a share buyback of approximately 49,000 shares at a cost of about HKD 999,400 on November 18, 2025 [1] Group 1 - The total expenditure for the share buyback is approximately HKD 999,400 [1] - The number of shares repurchased is 48,800 [1] - The date of the transaction is set for November 18, 2025 [1]